Conversion from Calcineurin Inhibitor to Sirolimus in Kidney Transplantation Recipients with Malignancy

被引:0
|
作者
Yoon, J. [1 ]
Kang, S. [1 ]
Kim, S. [1 ]
Baeck, C. [1 ]
Kim, H. [1 ]
Park, S. -K. [1 ]
机构
[1] Asan Med Ctr, Nephrol, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
D101
引用
收藏
页码:744 / 744
页数:1
相关论文
共 50 条
  • [1] Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients
    Martinez-Mier, Gustavo
    Mendez-Lopez, Marco Tulio
    Estrada-Oros, Jorge
    Budar-Fernandez, Luis F.
    Soto-Gonzalez, Juan I.
    Mendez-Machado, Gustavo F.
    Vinas Dozal, Julio Cesar
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (05) : 635 - 638
  • [2] Conversion to sirolimus for liver recipients with calcineurin inhibitor toxicity.
    McAlister, VC
    Peltekian, K
    Gao, Z
    Colohan, S
    Bitter-Suermann, H
    MacDonald, AS
    [J]. TRANSPLANTATION, 2000, 69 (08) : S315 - S315
  • [3] Conversion From Calcineurin Inhibitors to Sirolimus in Kidney Transplant Recipients: A Retrospective Cohort Study
    Cardinal, H.
    Froidure, A.
    Dandavino, R.
    Daloze, P.
    Hebert, M. J.
    Colette, S.
    Boucher, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (08) : 3308 - 3310
  • [4] Conversion from a calcineurin inhibitor to sirolimus in liver transplant recipients with chronic renal insufficiency.
    Dhir, R
    Quinn, MK
    Dennis, V
    Vogt, D
    Henderson, M
    Carey, W
    Levinthal, G
    Barnes, DS
    [J]. HEPATOLOGY, 2002, 36 (04) : 187A - 187A
  • [5] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    [J]. CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [6] Outcomes of sirolimus conversion for calcineurin inhibitor induced neurotoxicity in liver transplantation
    McKenna, Greg
    Kim, Peter T.
    Testa, Giuliano
    Ruiz, Richard
    Onaca, Nicholas
    Anthony, Tiffany
    Trotter, James
    Goldstein, Robert M.
    Klintmalm, Goran B.
    [J]. TRANSPLANTATION, 2016, 100 (07) : S351 - S351
  • [7] Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen
    Carvalho, Catarina
    Coentrao, Luis
    Bustorff, Manuela
    Patricio, Emilia
    Sampaio, Susana
    Santos, Joana
    Oliveira, Gerardo
    Pestana, Manuel
    [J]. CLINICAL TRANSPLANTATION, 2011, 25 (04) : E401 - E405
  • [8] Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patients
    Diekmann, F
    Fritsche, L
    Neumayer, HH
    Budde, K
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2004, 27 (03): : 186 - 190
  • [9] The effect of switching from calcineurin inhibitor to sirolimus on the incidence of skin cancers in kidney transplant recipients
    McQuillan, R. F.
    O'Seaghdha, C. M.
    Bagatto, A.
    Manusamy, M.
    Errakiah, N.
    Sinnott, C.
    O'Kelly, P.
    Murphy, G. M.
    Conlon, P. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (03) : 330 - 331
  • [10] Urothelial carcinoma in kidney transplant recipients: Conversion from calcineurin inhibitor to proliferation signal inhibitor?
    Chung, Shiu-Dong
    Lai, Ming-Kuen
    Wang, Shuo-Meng
    Liao, Chun-Hou
    Yu, Hong-Jeng
    Chueh, Shih-Chieh
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (03) : 630 - 630